November 11, 2014

IgE-Mediated allergy to wheat in a child with celiac disease - a case report

Case report

Tiffany Wong, Hin Hin Ko and Edmond S Chan

Author Affiliations

For all author emails, please log on.

Allergy, Asthma & Clinical Immunology 2014, 10:56 doi:10.1186/1710-1492-10-56

Published: 10 November 2014

IgE in Allergy (Williams)

November 9, 2014

Biochemical, Biophysical and IgE-Epitope Characterization of the Wheat Food Allergen, Tri a 37

2014 Nov 4;9(11):e111483. doi: 10.1371/journal.pone.0111483. eCollection 2014.

Pahr S1, Selb R2, Weber M3, Focke-Tejkl M3, Hofer G4, Dordić A4, Keller W4, Papadopoulos NG5, Giavi S5, Mäkelä M6, Pelkonen A6, Niederberger V2, Vrtala S1,Valenta R3.

Author information

Abstract

Wheat is an important staple food and potent allergen source. Recently, we isolated a cDNA coding for wheat alpha-purothionin which is recognized by wheat food allergic patients at risk for severe wheat-induced allergy.


Allergy Asthma Immunol Res. 2014 Nov;6(6):535-540. English. Published online May 27, 2014. http://dx.doi.org/10.4168/aair.2014.6.6.535

Abstract
Purpose Allergen-specific immunotherapy is the only currently available treatment to modify the natural history of allergic rhinitis (AR). If patients are polysensitized, it is difficult to identify the allergen causing the allergic symptoms. We evaluated the effectiveness of immunotherapy against house dust mites (HDMs) in AR patients polysensitized to both HDMs and seasonal allergens.

From the American Academy of Pediatrics

Clinical Practice Guideline

Shawn L. Ralston, MD, FAAP,

Allan S. Lieberthal, MD, FAAP,

H. Cody Meissner, MD, FAAP,

Brian K. Alverson, MD, FAAP,

Jill E. Baley, MD, FAAP,

Anne M. Gadomski, MD, MPH, FAAP,

David W. Johnson, MD, FAAP,

Michael J. Light, MD, FAAP,

Nizar F. Maraqa, MD, FAAP,

Eneida A. Mendonca, MD, PhD, FAAP, FACMI,

Kieran J. Phelan, MD, MSc,

Joseph J. Zorc, MD, MSCE, FAAP,

Danette Stanko-Lopp, MA, MPH,

Mark A. Brown, MD,

Ian Nathanson, MD, FAAP,

Elizabeth Rosenblum, MD,

Stephen Sayles III, MD, FACEP, and

Sinsi Hernandez-Cancio, JD

ABSTRACT

This guideline is a revision of the clinical practice guideline, “Diagnosis and Management of Bronchiolitis,” published by the American Academy of Pediatrics in 2006. The guideline applies to children from 1 through 23 months of age. Other exclusions are noted. Each key action statement indicates level of evidence, benefit-harm relationship, and level of recommendation. Key action statements are as follows:

Treatment outcomes of adenotonsillectomy for children with obstructive sleep apnea: a prospective longitudinal study

2014 Jan 1;37(1):71-6. doi: 10.5665/sleep.3310.

Huang YS1, Guilleminault C2, Lee LA3, Lin CH4, Hwang FM5.

Author information

Journal of Occupational Health
Vol. 55 (2013) No. 4 p. 318-321

Agnieszka Lipińska-Ojrzanowska¹⁾, Dominika Świerczyńska-Machura²⁾, Diana Tymoszuk¹⁾, Ewa Nowakowska-Świrta²⁾, Jolanta Walusiak-Skorupa¹⁾

1) Department of Occupational Diseases, Nofer Institute of Occupational Medicine 2) Centre of Occupational Allergy and Environmental Health, Nofer Institute of Occupational Medicine

Released on J-STAGE 20140206 [Advance Publication] Released 20130502

Keywords: Detergents, Dishwashing tablet, Occupational asthma (OA), Savinase, Sensitization to enzymes, Subtilisin

Language: